Clinical Trials Sponsored by Zhongshan Hospital Xiamen University

Total 584 results

The First Affiliated Hospital of Xiamen University

Recruiting

Evaluatioon of 177Lu-TATE-EB-01（LNC1010）in SSTR2-positive Tumors

SSTR2-positive Tumors

China
The First Affiliated Hospital of Xiamen University

Recruiting

PET Imaging of LAG-3 Expression

Tumor, Solid

China
The First Affiliated Hospital of Xiamen University

Recruiting

Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC

Colorectal Neoplasms

China
The First Affiliated Hospital of Xiamen University

Recruiting

A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy

Advanced Non-Small Cell Lung Cancer

China
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)

177Lu-DOTA-FAPI | 68Ga-DOTA-FAPI | Theranostic

China
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer

Multiple Primary Lung Cancer
The First Affiliated Hospital of Xiamen University

Recruiting

Diabetic Complications and Obstructive Sleep Apnea (DMOS)

Diabetic Complications and Obstructive Sleep Apnea

China
The First Affiliated Hospital of Xiamen University

Recruiting

Time Restricted Feeding on Impaired Glucose Regulation(TRIG Trial) (TRIG)

Impaired Glucose Regulation | Time-Restricted Feeding | Overweight/Obese

China
The First Affiliated Hospital of Xiamen University

Completed

APA on Sleep Quality in Women With PCOS

Polycystic Ovary Syndrome

China
The First Affiliated Hospital of Xiamen University

Completed

Time-Restricted Feeding(TRF) on Overweight/Obese Women With Polycystic Ovarian Syndrome (PCOS) (TRF-PCOS)

Overweight and Obesity | Polycystic Ovary Syndrome (PCOS)

China
The First Affiliated Hospital of Xiamen University

Completed

Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer

Positron-Emission Tomography | Tumor, Solid

China
The First Affiliated Hospital of Xiamen University

Active, not recruiting

Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC

Non-small Cell Lung Cancer Stage IV

China
The First Affiliated Hospital of Xiamen University

Unknown

18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

Lung Adenocarcinoma | PET/CT | 18F-FDG | 68Ga-FAPI

China
The First Affiliated Hospital of Xiamen University

Unknown

Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer

Locally Advanced Colon Cancer

China
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery

Pituitary Neoplasms
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer

Ovarian Cancer
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.

Primary Myelofibrosis

China
The First Affiliated Hospital of Xiamen University

Recruiting

Characterizing Myositis With 68Ga-FAPI PET/CT

Myositis | Idiopathic Inflammatory Myopathies

China
The First Affiliated Hospital of Xiamen University

Recruiting

Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN)

AF - Atrial Fibrillation | HTN-Hypertension

China
The First Affiliated Hospital of Xiamen University

Recruiting

Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients (LORMYF)

Rheumatoid Arthritis

China
The First Affiliated Hospital of Xiamen University

Recruiting

Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer

Refractory Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell Carcinoma

China
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Prevention In Community Clinics From Diabetic Kidney Disease (PICK)

Diabetic Nephropathies
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC

Lung Neoplasms
The First Affiliated Hospital of Xiamen University

Recruiting

A Nurse Cohort Study in Xiamen, China

Hypertension

China
The First Affiliated Hospital of Xiamen University

Completed

Difference Between Mean Gestational Sac Diameter and Crown-rump Length as a Marker of First-trimester Pregnancy Outcome in Patients With Recurrent Spontaneous Abortion (mGSD-CRL& RSA)

Recurrent Spontaneous Abortion

China
The First Affiliated Hospital of Xiamen University

Completed

68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG

Positron-Emission Tomography | Tumor, Solid

China
The First Affiliated Hospital of Xiamen University

Unknown

Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) (LiraGooD)

Overweight and Obesity | Hyperglycaemia (Diabetic) | Type 2 Diabetes Patients

China
The First Affiliated Hospital of Xiamen University

Completed

Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients

Diabetes Mellitus, Type 2

China
The First Affiliated Hospital of Xiamen University

Recruiting

Effect of Oliceridine on Rebound Pain

Rebound Pain | Arthroscopic Knee Surgery | Oliceridine

China
The First Affiliated Hospital of Xiamen University

Recruiting

Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer, mCRPC

China
The First Affiliated Hospital of Xiamen University

Recruiting

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors

Solid Tumor | Tumor | Positron-Emission Tomography

China
The First Affiliated Hospital of Xiamen University

Recruiting

All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma

Multiple Myeloma in Relapse | Multiple Myeloma, Refractory

China
The First Affiliated Hospital of Xiamen University

Recruiting

Graves' Disease Remission Study: MycoMeth Combo (3M-RGD)

Graves' Disease

China
The First Affiliated Hospital of Xiamen University

Recruiting

Individualized Precision Treatment Based on Ovarian Cancer Organoid Model

Ovarian Cancer

China
The First Affiliated Hospital of Xiamen University

Recruiting

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT

Gastric Cancer | Pancreatic Cancer | Liver Cancer

China
The First Affiliated Hospital of Xiamen University

Recruiting

Comparison of FDG and FAPI in Patients With Various Types of Cancer

Metastasis | Positron-Emission Tomography | Tumor, Solid

China
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial

Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety

China
The First Affiliated Hospital of Xiamen University

Enrolling by invitation

Efficacy and Safety Evaluation of Prebiotics Combined With Quadruple Probiotics in Improving Functional Constipation.

Effect of Prebiotics and Probiotics on Functional Constipation

China
The First Affiliated Hospital of Xiamen University

Completed

Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer

Tumor, Solid, FAPI, PET/CT, Metastasis

China
The First Affiliated Hospital of Xiamen University

Unknown

Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer

Locally Advanced or Metastatic Gastric Adenocarcinoma

China
The First Affiliated Hospital of Xiamen University

Unknown

Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer

NSCLC | Radiomics | Biopsy | Genomics | PET/CT | Whole-exome Sequencing

China
The First Affiliated Hospital of Xiamen University

Unknown

Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes

T2DM

China
The First Affiliated Hospital of Xiamen University

Unknown

SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy

Lung Cancer Metastatic

China
The First Affiliated Hospital of Xiamen University

Unknown

Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

Recurrence | Hepatocellular Carcinoma

China
Jilin University
Shanghai Zhongshan Hospital; First Affiliated Hospital Xi'an Jiaotong University and other collaborators

Not yet recruiting

IVUS Guided PCI for CKD to Reduce CI-AKI (IVUS-CKD)

Coronary Artery Disease | Chronic Kidney Diseases

China
Xiamen Amoytop Biotech Co., Ltd.
Peking University First Hospital

Completed

A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B

Chronic Hepatitis B

China
Xiamen Amoytop Biotech Co., Ltd.
Peking University First Hospital

Completed

Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy

Hepatitis B

China
Carponovum AB
The First Affiliated Hospital of Xiamen University

Completed

Clinical Trial Verifying C-REX LapAid and C-REX DMH/DMHC

Polyp of Colon | Cancer Colon

China
Xiamen Amoytop Biotech Co., Ltd.
Peking University First Hospital

Completed

A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B

Chronic Hepatitis B

China
Xiamen Amoytop Biotech Co., Ltd.
Peking University People's Hospital

Completed

Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C (PEGIFN)

Chronic Hepatitis C

China

Clinical Trials Sponsored by Zhongshan Hospital Xiamen University

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations